PTGX icon

Protagonist Therapeutics
PTGX

Overview Fund Activity

66 hedge funds and large institutions have $208M invested in Protagonist Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
30
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$12.3M
2
BBA
2
Baker Bros. Advisors
New York
$12.1M
3
ACP
3
Acuta Capital Partners
California
$8.13M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$6.69M
5
VMI
5
VHCP Management III
New York
$13M

Top Sellers

1
GTC
1
Ghost Tree Capital
New York
$2.42M
2
FCM
2
Farallon Capital Management
California
$18.2M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$0
4
WCM
4
Wedge Capital Management
North Carolina
$0
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$42.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
JG
76
Jefferies Group
New York
– -$177K -14,100 Closed
JT
77
Jump Trading
Illinois
– -$159K -12,624 Closed
SIM
78
Spark Investment Management
New York
– -$126K -10,100 Closed
KPW
79
Kore Private Wealth
New York
– -$13K -1,000 Closed
1 2 3
4